SEC Form 4 · accession 0001140361-15-044054
IRADIMED CORP · IRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven M. Nardi
Officer — VP of Manufacturing
Period of report
Dec 7, 2015
Accepted (ET)
Dec 9, 2015 · 6:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001325618
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 7, 2015 | A | 624 | $1.48 | A | 1,724 | D | |
| Common Stock | Dec 7, 2015 | S | 300 | $31.00 | D | 1,424 | D | |
| Common Stock | Dec 7, 2015 | S | 100 | $31.01 | D | 1,324 | D | |
| Common Stock | Dec 7, 2015 | S | 24 | $31.07 | D | 1,200 | D | |
| Common Stock | Dec 7, 2015 | S | 200 | $31.035 | D | 1,100 | D | |
| Common Stock | Dec 8, 2015 | S | 500 | $30.99 | D | 600 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $1.48 | Dec 7, 2015 | M | 624 | D | — | Dec 29, 2023 | Common Stock | 624 | 6,563 | D |
Explanation of responses
- F1Reflects a corrected amount of shares Beneficially Owned following Reported Transactions on Form 4 filed on 12/08/2015.
- F2This option, representing a right to purchase a total of 8,750 shares, was granted on 12/31/2013 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.